Stories Tagged as
Theranos
"Due diligence" is part of the vernacular. But what does it really mean?
by
Matt Levin
Apr 5, 2023
Recent scandals involving FTX and Frank leave some wondering if enough research was done on the startups, and who was supposed to do it.
What Elizabeth Holmes' guilty verdict means for Silicon Valley
by
David Brancaccio
and Rose Conlon
Jan 4, 2022
Theranos founder Elizabeth Holmes was convicted of four counts of fraud in a case that's viewed as a landmark test of Silicon Valley startup culture.
Is Elizabeth Holmes guilty of fraud? A jury is deliberating.
by
David Brancaccio
and Rose Conlon
Dec 21, 2021
The trial of the Theranos founder is seen as a bellwether for Silicon Valley.
Former execs at Safeway, Walgreens testify at trial of Theranos founder
by
David Brancaccio
and Rose Conlon
Oct 14, 2021
Testimony from the former CEO of Safeway and the ex-CFO of Walgreens illuminates those companies' dealings with Elizabeth Holmes.
The Enron scandal: 20 years later, what’s changed?
by
David Brancaccio
and Rose Conlon
Sep 23, 2021
Very little, according to Bethany McLean, the first financial reporter to ask questions about Enron's accounting practices.
Inside the trial of Theranos' Elizabeth Holmes
by
David Brancaccio
and Rose Conlon
Sep 14, 2021
And what the case means for Silicon Valley.
What it means to be a whistleblower
Jul 30, 2018
What are the benefits? Risks? And are you protected?
For public good, not for profit.
Will the Theranos scandal put a damper on medical tech investing?
by
Molly Wood
and Stephanie Hughes
Jun 19, 2018
It's become a cautionary tale for biotech investors. Are they heeding it?
How Theranos, a Silicon Valley star, came tumbling down
by
Kai Ryssdal
and Bridget Bodnar
May 21, 2018
Wall Street Journal investigative reporter John Carreyrou discovered that all wasn't as it appeared at Theranos, the biotech company founded by Elizabeth Holmes.
Holmes surrenders Theranos, pays $500K after "massive fraud"
Mar 14, 2018
The settlement comes two years after the SEC began looking into claims at Theranos that it had developed potentially revolutionary blood-testing technology.